CILGAVIMAB: 46 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
46
Total FAERS Reports
7 (15.2%)
Deaths Reported
8
Hospitalizations
46
As Primary/Secondary Suspect
4
Life-Threatening
First Report: 20211215 · Latest Report: 20221229
What Are the Most Common CILGAVIMAB Side Effects?
#1 Most Reported
Nausea
8 reports (17.4%)
#2 Most Reported
Toxic epidermal necrolysis
7 reports (15.2%)
#3 Most Reported
Covid-19
6 reports (13.0%)
All CILGAVIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 8 | 17.4% | 0 | 2 |
| Toxic epidermal necrolysis | 7 | 15.2% | 7 | 0 |
| Covid-19 | 6 | 13.0% | 0 | 3 |
| Chest discomfort | 5 | 10.9% | 0 | 0 |
Who Reports CILGAVIMAB Side Effects? Age & Gender Data
Gender: 61.0% female, 39.0% male. Average age: 55.4 years. Most reports from: US. View detailed demographics →
Is CILGAVIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 1 | 1 | 0 |
| 2022 | 39 | 6 | 6 |
What Is CILGAVIMAB Used For?
| Indication | Reports |
|---|---|
| Covid-19 | 19 |
| Covid-19 prophylaxis | 12 |
Official FDA Label for CILGAVIMAB
Official prescribing information from the FDA-approved drug label.